ducovest

MDYV:ARCA-SPDR S&P 400 Mid Cap Value ETF (based on S&P MidCap 400 Value Index--symbol: MGD (USD)

ETF | Mid-Cap Value | NYSE Arca

Last Closing

USD 77.62

Change

0.00 (0.00)%

Market Cap

USD 0.33B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P MidCap 400 Value Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index measures the performance of the mid-capitalization value segment of the U.S. equity market. It may purchase a subset of the securities in the index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the index. The fund is non-diversified.

Company Website : www.spdrs.com

Currency: USD

Country : USA

Inception Date: 08/11/2005

Primary Benchmark: S&P MidCap 400 Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.15%

Management Expense Ratio: 0.15 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 1.23 %
PLXS Plexus Corp 0.89 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-14 )

Largest Industry Peers for Mid-Cap Value

Symbol Name Mer Price(Change) Market Cap
VOE Vanguard Mid-Cap Value Index F.. 0.07 %

N/A

 USD 17.96B
IWS iShares Russell Mid-Cap Value .. 0.24 %

N/A

 USD 12.48B
IJJ iShares S&P Mid-Cap 400 Value .. 0.25 %

N/A

 USD 7.52B
PVAL Putnam Focused Large Cap Value.. 0.29 %

N/A

 USD 2.91B
KOMP SPDR Kensho New Economies Comp.. 0.00 %

N/A

 USD 2.20B
IVOV Vanguard S&P Mid-Cap 400 Value.. 0.20 %

N/A

 USD 0.89B
XMLV Invesco S&P MidCap Low Volatil.. 0.25 %

N/A

 USD 0.81B
DIV Global X SuperDividend U.S. ET.. 0.46 %

N/A

 USD 0.63B
VUSE Vident Core U.S. Equity Fund 0.51 %

N/A

 USD 0.60B
XMVM Invesco S&P MidCap Value with .. 0.39 %

N/A

 USD 0.26B

ETFs Containing MDYV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Value) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.22% 20% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.22% 19% F 32% F
Trailing 12 Months  
Capital Gain 7.46% 50% F 63% D
Dividend Return 1.04% 50% F 22% F
Total Return 8.50% 50% F 59% D-
Trailing 5 Years  
Capital Gain 78.19% 69% C- 72% C
Dividend Return 12.22% 63% D 33% F
Total Return 90.41% 63% D 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 8.67% 50% F 69% C-
Dividend Return 9.89% 50% F 66% D+
Total Return 1.22% 50% F 28% F
Risk Return Profile  
Volatility (Standard Deviation) 19.73% 56% F 49% F
Risk Adjusted Return 50.12% 50% F 67% D+
Market Capitalization 0.33B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.